Acceleration of ageing via disturbing mTOR-regulated proteostasis by a new ageing-associated gene PC4.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
06 2021
Historique:
revised: 21 02 2021
received: 27 11 2020
accepted: 31 03 2021
pubmed: 7 5 2021
medline: 29 12 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

Research on ageing-associated genes is important for investigating ageing and anti-ageing strategies. Here, we firstly reported that the human positive cofactor 4 (PC4), a multifunctional and highly conserved nucleoprotein, is accumulated and activated during ageing and causes global accelerated ageing process by disrupting proteostasis. Mechanistically, PC4 interacts with Sin3-HDAC complex and inhibits its deacetylated activity, leads to hyper-acetylation of the histones at the promoters of mTOR-related genes and causes mTOR signalling activation. Accordingly, mTOR activation causes excessive protein synthesis, resulting in impaired proteostasis and accelerated senescence. These results reveal a new biological function of PC4 in vivo, recognizes PC4 as a new ageing-associated gene and provides a genetically engineered mouse model to simulate natural ageing. More importantly, our findings also indicate that PC4 is involved in histone acetylation and serves as a potential target to improve proteostasis and delay ageing.

Identifiants

pubmed: 33957702
doi: 10.1111/acel.13370
pmc: PMC8208792
doi:

Substances chimiques

DNA-Binding Proteins 0
SUB1 protein, human 0
Transcription Factors 0
MTOR protein, human EC 2.7.1.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13370

Informations de copyright

© 2021 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

Références

Cell. 1994 Aug 12;78(3):513-23
pubmed: 8062391
Transcription. 2018;9(1):52-60
pubmed: 28853990
Autophagy. 2015;11(12):2309-22
pubmed: 26735435
Adv Exp Med Biol. 2017;1002:189-208
pubmed: 28600787
Saudi J Biol Sci. 2017 Jan;24(1):108-113
pubmed: 28053579
Mol Cell Biol. 2006 Nov;26(22):8303-15
pubmed: 16982701
Autophagy. 2019 Nov;15(11):2028-2030
pubmed: 31480882
Br J Pharmacol. 2019 Dec;176 Suppl 1:S1-S20
pubmed: 31710719
Sci Rep. 2016 Jan 05;6:18722
pubmed: 26729469
Cell. 2019 Oct 31;179(4):813-827
pubmed: 31675495
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Oncogene. 2016 Feb 11;35(6):761-70
pubmed: 25961912
J Biol Chem. 2016 Sep 23;291(39):20303-14
pubmed: 27471272
Nature. 2009 Jul 16;460(7253):392-5
pubmed: 19587680
Nat Med. 2015 Dec;21(12):1406-15
pubmed: 26646497
Curr Genet. 2017 Dec;63(6):1023-1035
pubmed: 28567479
Curr Mol Med. 2018;18(3):178-189
pubmed: 30198430
Nucleic Acids Res. 2016 Feb 18;44(3):1203-15
pubmed: 26740582
Cell Res. 2019 Feb;29(2):136-150
pubmed: 30514904
Biochim Biophys Acta Gene Regul Mech. 2018 Oct;1861(10):971-981
pubmed: 30496042
Annu Rev Biochem. 2015;84:435-64
pubmed: 25784053
Exp Gerontol. 2015 Mar;63:27-34
pubmed: 25597278
Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):767-774
pubmed: 31478386
Cell. 2014 Mar 13;156(6):1167-1178
pubmed: 24630720
J Biol Chem. 2011 Mar 4;286(9):7681-91
pubmed: 21193408
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
FEBS J. 2016 Mar;283(6):968-85
pubmed: 26777301
Nature. 2013 Jan 17;493(7432):338-45
pubmed: 23325216
J Biochem. 2019 Nov 1;166(5):403-413
pubmed: 31236588
Nat Commun. 2017 Jul 24;8(1):155
pubmed: 28761067
Cell. 2019 Feb 21;176(5):1083-1097.e18
pubmed: 30739799
Annu Rev Biochem. 2016 Jun 2;85:1-4
pubmed: 27050288
Mol Cell Biochem. 2016 Jan;412(1-2):165-71
pubmed: 26708217
Nature. 2002 Jan 3;415(6867):45-53
pubmed: 11780111
Nucleic Acids Res. 2019 Sep 26;47(17):9115-9131
pubmed: 31372634
Mol Cell. 2019 Feb 21;73(4):684-698.e8
pubmed: 30773298
FEBS J. 2006 Apr;273(7):1430-44
pubmed: 16689930
Biochim Biophys Acta. 2013 Mar-Apr;1819(3-4):322-31
pubmed: 24459734
Curr Biol. 2019 Mar 4;29(5):737-749.e5
pubmed: 30773367
Cell Cycle. 2015;14(4):473-80
pubmed: 25590164
Cell. 2017 Apr 20;169(3):470-482.e13
pubmed: 28431247
Aging Cell. 2020 Jan;19(1):e13060
pubmed: 31773901
FEBS J. 2019 Nov;286(22):4422-4442
pubmed: 31169983
Burns Trauma. 2020 May 05;8:tkaa010
pubmed: 32373645

Auteurs

Long Chen (L)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Fengying Liao (F)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Jie Wu (J)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Ziwen Wang (Z)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.
Department of Cardiology, Geriatric Cardiovascular Disease Research and Treatment Center, 252 Hospital of PLA (82nd Group Army Hospital of PLA), Baoding, China.

Zhongyong Jiang (Z)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Chi Zhang (C)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Peng Luo (P)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Le Ma (L)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Qiang Gong (Q)

Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.

Yang Wang (Y)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Qing Wang (Q)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Min Luo (M)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Zeyu Yang (Z)

Breast and Thyroid Surgical Department, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China.

Shiqian Han (S)

Institute of Tropical Medicine, Third Military Medical University, Chongqing, China.

Chunmeng Shi (C)

Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH